Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Takahashi H, Ohigashi H, Tomita Y, Ishikawa O, Mori M, Doki Y.
Akita H, et al. Among authors: mori m.
Oncogene. 2011 Aug 4;30(31):3468-76. doi: 10.1038/onc.2011.59. Epub 2011 Mar 14.
Oncogene. 2011.
PMID: 21399662